Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

2.09
Delayed Data
As of 3:59pm ET
 -0.02 / -0.95%
Today’s Change
0.80
Today|||52-Week Range
8.12
+72.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization145.0K257.0K43.0K24.0K
 
 
 
 
 
 
Operating ExpensesGross Income-145.0K-257.0K-43.0K-24.0K
 
 
 
 
 
General Expenses18.0M27.5M32.5M29.2M
 
 
 
 
 
Research And Development13.3M22.9M27.1M24.1M
 
 
 
 
 
Total Operating Expenses18.2M27.7M32.5M29.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.2M-27.7M-32.5M-29.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.2M-27.7M-32.5M-29.2M
 
 
 
 
 
Net Income-18.2M-27.7M-32.5M-29.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.3M20.8M23.4M24.3M
 
 
 
 
 
Shares To Calculate EPS Diluted15.3M20.8M23.4M24.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.18-$1.33-$1.39-$1.20
 
 
 
 
 
EPS Diluted-$1.18-$1.33-$1.39-$1.20